首页 | 官方网站   微博 | 高级检索  
     

多巴胺与去甲肾上腺素治疗感染性休克疗效比较的系统评价
引用本文:赵阳,王倩,臧彬.多巴胺与去甲肾上腺素治疗感染性休克疗效比较的系统评价[J].中国循证医学杂志,2012,12(6):679-685.
作者姓名:赵阳  王倩  臧彬
作者单位:1. 中国医科大学附属盛京医院ICU,沈阳,110004
2. 中国医科大学附属第四医院急诊科,沈阳,110032
摘    要:目的系统评价多巴胺与去甲肾上腺素治疗感染性休克的疗效及安全性。方法计算机检索MEDLINE、EMbase、Cochrane图书馆、VIP、CNKI、CBM和WanFang Data等数据库(检索时限均从建库至2011年6月),纳入所有使用多巴胺或去甲肾上腺素治疗感染性休克的随机对照试验(RCT)。评价纳入研究的方法学质量和提取有效数据后,采用RevMan 5.1软件进行Meta分析。结果共纳入9个RCT,3 179例休克患者。Meta分析结果显示:多巴胺同去甲肾上腺素相比,能使感染性休克患者住院期间死亡风险增加12%,其差异具有统计学意义RR=1.12,95%CI(1.04,1.21),P=0.002];多巴胺组感染性休克患者心率失常事件发生风险是去甲肾上腺素组的2.63倍RR=2.63,95%C(I1.51,4.55),P=0.000 6];多巴胺组心脏指数较去甲肾上腺素组增加MD=0.42,95%C(I0.21,0.63),P<0.000 1];但在心率MD=17.05,95%CI(–0.71,34.81),P=0.06]及平均动脉压MD=–0.87,95%CI(–24.97,7.62),P=0.30]方面,两组差异无统计学意义。结论去甲肾上腺素同多巴胺相比能显著降低感染性休克患者住院期间死亡率,降低心律失常事件的发生率,其疗效及安全性优于多巴胺。

关 键 词:多巴胺  去甲肾上腺素  感染性休克  随机对照试验  系统评价  Meta分析

Dopamine versus Norepinephrine for Septic Shock:A Systemic Review
ZHAO Yang , WANG Qian , ZANG Bin.Dopamine versus Norepinephrine for Septic Shock:A Systemic Review[J].Chinese Journal of Evidence-based Medicine,2012,12(6):679-685.
Authors:ZHAO Yang  WANG Qian  ZANG Bin
Affiliation:1.Department of ICU,Shengjing Hospital Affiliated to China Medical University,Shenyang 110004,China; 2.Department of Emergency,the 4th Hospital Affiliated to China Medical University,Shenyang 110032,China
Abstract:Objective To systemically review the efficacy and safety of dopamine versus norepinephrine in patients with septic shock.Methods Database searches of MEDLINE,EMbase,Cochrane Controlled Trials Register,VIP,CNKI,and CBM(from the date of database establishment to June 2011) were conducted.Additional studies for collecting relevant data were retrieved via both references of articles and direct contact with authors.Prospectively,randomized controlled trials(RCTs) of dopamine compared with norepinephrine therapy in septic shock patients were selected.The quality of included trials was assessed and relevant data were extracted.Then statistical analysis was performed using RevMan 5.1.Results Nine trials with 3 179 participants were included.The results of meta-analysis showed: compared with norepinephrine,dopamine was associated with a significant 12% elevation in the risk ratio of in-hospital death events of septic shock patients(RR=1.12,95%CI 1.04 to 1.21,P=0.002).The risk of arrhythmias in dopamine group was 2.63-fold than that in norepinephrine group(RR=2.63,95%CI 1.51 to 4.55,P=0.000 6).The cardiac index of septic patients in dopamine group was higher than that in norepinephrine group(MD=0.42,95%CI 0.21 to 0.63,P<0.000 1).No significant difference could be found in the heart rate(MD=17.05,95%CI –0.71 to 34.81,P=0.06) and mean arterial pressure(MD= –0.87,95%CI –24.97 to 7.62,P=0.30).Conclusion Findings from this meta-analysis suggest that compared with dopamine,norepinephrine significantly reduces both 28-day mortality of septic shock patients and incidence rate of arrhythmias.Norepinephrine is better than dopamine in aspects of efficacy and safety.
Keywords:Dopamine  Norepinephrine  Septic shock  Randomized controlled trial  Systemic review  Meta-analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号